Primary Mediastinal Large B-Cell Lymphoma: Results of Intensive Chemotherapy Regimens (MACOP-B/VACOP-B) Plus Involved Field Radiotherapy on 53 Patients. A Single Institution Experience

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 3, 2007, Pages 823-829

  Mazzarotto, Renzo ^a   Boso, Caterina ^a   Vianello, Federica ^a   Aversa, Maria Savina ^a   Chiarion Sileni, Vanna ^a   Trentin, Livio ^a   Zambello, Renato ^a   Muzzio, Pier Carlo ^a   Fiore, Davide ^a   Sotti, Guido ^a  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Combined modality treatment; Intensive chemotherapy regimens; Primary mediastinal large B cell lymphoma; Radiation therapy

Indexed keywords

BIOMEDICAL ENGINEERING; CHEMOTHERAPY; MODAL ANALYSIS; RADIOTHERAPY;

COMBINED MODALITY TREATMENT; INTENSIVE CHEMOTHERAPY REGIMENS; PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA;

CELLS;

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFECTION; INVOLVED FIELD RADIOTHERAPY; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM CANCER; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT PLANNING;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INCIDENCE; ITALY; LYMPHOMA, B-CELL; MALE; MEDIASTINUM; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34249333499     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.12.048     Document Type: Article

References (26)

1. Falini B., Venturi S., Martelli M., et al. Mediastinal large B-cell lymphoma. Clinical and immunohistological findings in 18 patients treated with different third-generation regimens. Br J Haematol 89 (1995) 780-789
2. Cazals-Hatem D., Lepage E., Brice P., et al. Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 non-mediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study. Am J Surg Pathol 20 (1996) 877-888
3. Savage K.J. Primary mediastinal large B-cell lymphoma. Oncologist 11 (2006) 488-495
4. Harris N.L., Jaffe E.S., Stein H., et al. A revised European-American classification of lymphoid neoplasm: A proposal from the International Lymphoma Study Group. Blood 84 (1994) 1361-1391
5. Menestrina F., Chilosi M., Bonetti F., et al. Mediastinal large cell lymphomas of B-type, with sclerosis: Histopathological and immunohistochemical study of eight cases. Histopathology 10 (1986) 589-600
6. Todeschini G., Secchi S., Morra E., et al. Primary mediastinal large B-cell lymphoma (PMLBCL): Long-term results from a retrospective multicenter Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B. Br J Cancer 90 (2004) 372-376
7. Todeschini G., Ambrosetti A., Meneghini V., et al. Mediastinal large B cell lymphoma with sclerosis. A clinical study of 21 patients. J Clin Oncol 8 (1990) 804-808
8. Lazzarino M., Orlandi E., Paulli M., et al. Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: A multicenter study of 106 patients. J Clin Oncol 15 (1997) 1646-1653
9. Perrone T., Frizzera G., Rosai J., et al. Mediastinal diffuse large cell Lymphoma with sclerosis. A clinicopathologic study of 60 cases. Am J Surg Pathol 10 (1986) 176-191
10. Zinzani P.L., Martelli M., Bertini M., et al. Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: A retrospective multinational study on 426 previously untreated patients. Haematologica 87 (2002) 1258-1264
11. Savage K.J., Al-Rajhi N., Voss N., et al. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: The British Columbia experience. Ann Oncol 17 (2006) 123-130
12. Shipp M., Harrington D., Anderson J., et al. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329 (1993) 987-994
13. Harris N.L., Jaffe E.S., Diebold J., et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 10 (1999) 1419-1432
14. Isaacson P.G., Norton A.J., Addis B.J., et al. The human thymus contains a novel population of B lymphocytes. Lancet 2 (1987) 1488-1491
15. Lamarre L., Jacobson J.O., Aisemberg A.C., et al. Primary lymphoma of the mediastinum. A histologic and immunophenotypic study of 29 cases. Am J Surg Pathol 13 (1989) 730-739
16. van Besien K., Kelta M., and Bahaguna P. Primary mediastinal B-cell lymphoma: A review of pathology and management. J Clin Oncol 19 (2001) 1855-1864
17. Lazzarino M., Orlandi E., Paulli M., et al. Primary mediastinal B-cell lymphoma with sclerosis. An aggressive tumor with distinctive clinical and pathologic features. J Clin Oncol 11 (1993) 2306-2311
18. Fisher R.I., Gaynor E.R., Dahlberg S., et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328 (1993) 1002-1006
19. Zinzani P.L., Martelli M., De Renzo A., et al. Primary mediastinal large B-cell lymphoma with sclerosis: A clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy. Haematologica 86 (2001) 187-191
20. Kirn D., Mauch P., Shaffer K., et al. Large-cell and immunoblastic lymphoma of the mediastinum. Prognostic and pathologic features in 57 patients. J Clin Oncol 11 (1993) 1336-1343
21. Haioun C., Gaulard P., Roudot-Thoraval F., et al. Mediastinal diffuse large-cell lymphoma with sclerosis: A condition with a poor prognosis. Am J Clin Oncol 12 (1989) 425-429
22. Zinzani P.L., Martelli M., Magagnoli M., et al. Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by 67Gallium scan in 50 patients. Blood 94 10 (1999) 3289-3293
23. Travis L.B., Hill D., Dores G.M., et al. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst 97 (2005) 1428-1437
24. Preston D.L., Mattsson A., Holmberg E., et al. Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat Res 158 (2002) 220-235
25. Travis L.B., Hill D.A., Dores G.M., et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 290 (2003) 465-475
26. van Leeuwen F.E., Klokman W.J., Stovall M., et al. The roles of radiation dose, chemotherapy and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 95 (2003) 941-947